As a leading biotech company we believe that by using industrial biotechnology we can potentially re-engineer thousands of everyday products to deliver enhanced sustainability performance, at no extra cost. It is a compelling proposition, but one backed by strong evidence. We already market over
700 biotechnology products in 130 countries.
The enzyme production leaves Novozymes with a global enzyme market share of 47% (2011).
Read more about enzymes, see
images of our enzyme production, or
learn more about enzyme production.
Novozymes is dedicated to biotech partnerships
However, we know that we cannot institute change on a global scale in isolation. Central to Novozymes' strategy is a dedication to driving change in close alliance with our customers. By combining our biotechnology with our customers’ industry insights we are able to gain higher yields and product performance while reducing environmental impact in a whole host of categories.
Shaping the business of today and tomorrow
Novozymes’ biotechnology enables everything from the removal of trans fats in food to advancements in renewable energy sources. Our never-ending exploration of nature’s potential is evidenced by over 6,000 patents – an indication of what is possible when nature and technology join forces in biotechnology, and we are continuously and proactively seeking partners to license or inlicense patents within our interest areas.
Our 5,500+ employees working in research, production, and sales around the world are committed to shaping the businesses of today and the world of tomorrow.
For further information, please read
our company profile in the 2011 annual report.